Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Recently characterized MUC17 gene highly specific for pancreatic cancer. More
Nanoparticles that exhibit high epithelial uptake and transepithelial transport More
An siRNA type therapeutics delevary system More
precise and focused control of temperature mediated therapy and “triggering” deliverables in situ. More
Novel agents capable of reaching remote cellular sites More
Improved accuracy in pattern recognition of clustered multidimensional data More
This invention will be useful in greatly improving overall results of microarray experiments. More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Related Reports
Market Research Reports provided by reports.innovaro.com
Dec 2010 - 15 pages - $500
Dec 2010 - 16 pages - $500
Dec 2010 - 25 pages - $500
Nov 2010 - 68 pages - $600
Nov 2010 - 56 pages - $600
Nov 2010 - 92 pages - $600
Nov 2010 - 179 pages - $600
Nov 2010 - 60 pages - $600
Mar 2011 - 26 pages - $500
Nov 2010 - 49 pages - $600
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us